Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: axial who wrote (11820)	1/5/2003 2:52:25 PM
From: shakedown	Read Replies (2) of 14101

DMX mentioned in Toronto Star article: torontostar.com Stanley has also bought into Dimethaid Research Inc. (TSX: DMX), a pharmaceutical company based in Markham. Dimethaid's two technology platforms focus on transcellular drug delivery and immune system regulation, with applications in such areas as relieving osteoarthritic pain and combating opportunistic infections associated with AIDS. Stanley had previously owned shares in the company, but sold out of it in 2000. Even though he knew that Dimethaid, which had no earnings yet, had wonderful products in development, the stock (which had climbed to the mid teens) had "gotten way ahead of itself. Dimethaid, which now trades about $2.20, came down to levels that made it attractive again, says Stanley, who started buying it in the $2 range.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next